FdaApplication
NDA 205832
Identifiers
- fda_app_no: NDA205832
Properties
| Property | Value |
|---|---|
| applicant_name | BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2014-10-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OFEV | NINTEDANIB ESYLATE | EQ 100MG BASE | CAPSULE;ORAL |
| OFEV | NINTEDANIB ESYLATE | EQ 150MG BASE | CAPSULE;ORAL |
2 products